Additional effects of bisphenol A and paraben on the induction of calbindin-D9K and progesterone receptor via an estrogen receptor pathway in rat pituitary GH3 cells

Journal of Physiology and Pharmacology

Volumn 63, Issue 5, 2012, Pages 445-455

  Kim, S M ^a   Jung, E M ^a   An, B S ^a,d   Hwang, I ^a   Vo, T T ^a   Kim, S R ^b   Lee, S M ^c   Choi, K C ^a   Jeung, E B ^a  

^a Chungbuk National University   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Chongju University   (South Korea)

^d Pusan National University   (South Korea)

Author keywords

17 estradiol; Bisphenol A; Calbindin D9K; Cancer; Estrogen receptor; GH3 cells; Isobutylparaben; Progesterone receptor

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; 4,4' ISOPROPYLIDENEDIPHENOL; CALBINDIN; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; ISOBUTYL PARABEN; LUCIFERASE; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALBINDIN GENE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; HYPOPHYSIS CELL; NONHUMAN; PLASMID; PROGESTERONE RECEPTOR GENE; PROTEIN EXPRESSION; RAT; REPORTER GENE; RNA TRANSLATION; UPREGULATION;

ANIMALS; BENZHYDRYL COMPOUNDS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL LINE; ENDOCRINE DISRUPTORS; ESTROGENS, NON-STEROIDAL; PARABENS; PHENOLS; PITUITARY GLAND; RATS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RESPONSE ELEMENTS; RNA, MESSENGER;

EID: 84870604487     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Ozen S and Darcan S. Effects of environmental endocrine disruptors on pubertal development. J Clin Res Pediatr Endocrinol 2011; 3: 1-6.
2. Kortenkamp A, Altenburger R. Synergisms with mixtures of xenoestrogens: a reevaluation using the method of isoboles. Sci Total Environ 1998; 221: 59-73.
3. Kortenkamp A, Altenburger R. Approaches to assessing combination effects of oestrogenic environmental pollutants. Sci Total Environ 1999; 233: 131-140.
4. Carpenter DO, Arcaro K, Spink DC. Understanding the human health effects of chemical mixtures. Environ Health Perspect 2002; 110(Suppl. 1): 25-42.
5. Cantonwine D, Meeker JD, Hu H, et al. Bisphenol a exposure in Mexico City and risk of prematurity: a pilot nested case control study. Environ Health 2010; 9: 62.
6. Barrett JR. The Pharmacokinetics of BPA: similarities in human and animal metabolism suggest higher exposure than thought. Environ Health Perspect 2011; 119: a177.
7. Gould JC, Leonard LS, Maness SC, et al. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol Cell Endocrinol 1998; 142: 203-214.
8. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-4263.
9. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007; 24: 139-177.
10. Steinmetz R, Brown NG, Allen DL, Bigsby RM, Ben-Jonathan N. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology 1997; 138: 1780-1786.
11. Markey CM, Michaelson CL, Veson EC, Sonnenschein C, Soto AM. The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ Health Perspect 2001; 109: 55-60.
12. Darbre PD, Harvey PW. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol 2008; 28: 561-578.
13. Cashman AL, Warshaw EM. Parabens: a review of epidemiology, structure, allergenicity, and hormonal properties. Dermatitis 2005; 16: 57-66; quiz 55-56.
14. Golden R, Gandy J, Vollmer G. A review of the endocrine activity of parabens and implications for potential risks to human health. Crit Rev Toxicol 2005; 35: 435-458.
15. Vo TT, Jeung EB. An evaluation of estrogenic activity of parabens using uterine calbindin-d9k gene in an immature rat model. Toxicol Sci 2009; 112: 68-77.
16. Morohoshi K, Yamamoto H, Kamata R, Shiraishi F, Koda T, Morita M. Estrogenic activity of 37 components of commercial sunscreen lotions evaluated by in vitro assays. Toxicol In Vitro 2005; 19: 457-469.
17. Vo TT, Jung EM, Choi KC, Yu FH, Jeung EB. Estrogen receptor alpha is involved in the induction of calbindin-D(9k) and progesterone receptor by parabens in GH3 cells: a biomarker gene for screening xenoestrogens. Steroids 2011; 76: 675-681.
18. Soni MG, Carabin IG, Burdock GA. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem Toxicol 2005; 43: 985-1015.
19. Erler C, Novak J. Bisphenol a exposure: human risk and health policy. J Pediatr Nurs 2010; 25: 400-407.
20. Jung EM, An BS, Yang H, Choi KC, Jeung EB. Biomarker genes for detecting estrogenic activity of endocrine disruptors via estrogen receptors. Int J Environ Res Public Health 2012; 9: 698-711.
21. Choi KC, Jeung EB. Molecular mechanism of regulation of the calcium-binding protein calbindin-D9k, and its physiological role(s) in mammals: a review of current research. J Cell Mol Med 2008; 12: 409-420.
22. Dang VH, Nguyen TH, Lee GS, Choi KC, Jeung EB. In vitro exposure to xenoestrogens induces growth hormone transcription and release via estrogen receptor-dependent pathways in rat pituitary GH3 cells. Steroids 2009; 74: 707-714.
23. Dang VH, Choi KC, Jeung EB. Membrane-impermeable estrogen is involved in regulation of calbindin-D9k expression via non-genomic pathways in a rat pituitary cell line, GH3 cells. Toxicol In Vitro 2010; 24: 1229-1236.
24. Jung EM, An BS, Choi KC, Jeung EB. Potential estrogenic activity of triclosan in the uterus of immature rats and rat pituitary GH3 cells. Toxicol Lett 2012; 208: 142-148.
25. An BS, Choi KC, Kang SK, Hwang WS, Jeung EB. Novel calbindin-D(9k) protein as a useful biomarker for environmental estrogenic compounds in the uterus of immature rats. Reprod Toxicol 2003; 17: 311-319.
26. Armbrecht HJ, Boltz M, Strong R, Richardson A, Bruns ME, Christakos S. Expression of calbindin-D decreases with age in intestine and kidney. Endocrinology 1989; 125: 2950-2956.
27. Mathieu CL, Burnett SH, Mills SE, Overpeck JG, Bruns DE, Bruns ME. Gestational changes in calbindin-D9k in rat uterus, yolk sac, and placenta: implications for maternal-fetal calcium transport and uterine muscle function. Proc Natl Acad Sci USA 1989; 86: 3433-3437.
28. An BS, Choi KC, Kang SK, et al. Mouse calbindin-D(9k) gene expression in the uterus during late pregnancy and lactation. Mol Cell Endocrinol 2003; 205: 79-88.
29. An BS, Choi KC, Hong EJ, Jung YW, Manabe N, Jeung EB. Differential transcriptional and translational regulations of calbindin-D9k by steroid hormones and their receptors in the uterus of immature mice. J Reprod Dev 2004; 50: 445-453.
30. Choi KC, An BS, Yang H, Jeung EB. Regulation and molecular mechanisms of calcium transport genes: do they play a role in calcium transport in the uterine endometrium? J Physiol Pharmacol 2012; 62: 499-504.
31. Lee KY, Oh GT, Kang JH, et al. Transcriptional regulation of the mouse calbindin-D9k gene by the ovarian sex hormone. Mol Cells 2003; 16: 48-53.
32. Darwish H, Krisinger J, Furlow JD, Smith C, Murdoch FE, DeLuca HF. An estrogen-responsive element mediates the transcriptional regulation of calbindin D-9K gene in rat uterus. J Biol Chem 1991; 266: 551-558.
33. Lee GS, Kim HJ, Jung YW, Choi KC, Jeung EB. Estrogen receptor alpha pathway is involved in the regulation of calbindin-D9k in the uterus of immature rats. Toxicol Sci 2005; 84: 270-277.
34. Fujimoto N, Igarashi K, Kanno J, Inoue T. Identification of estrogen-responsive genes in the GH3 cell line by cDNA microarray analysis. J Steroid Biochem Mol Biol 2004; 91: 121-129.
35. Kansra S, Yamagata S, Sneade L, Foster L, Ben-Jonathan N. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Mol Cell Endocrinol 2005; 239: 27-36.
36. Kim YR, Jung EM, Choi KC, Jeung EB. Synergistic effects of octylphenol and isobutyl paraben on the expression of calbindin-D(9)k in GH3 rat pituitary cells. Int J Mol Med 2012; 29: 294-302.
37. Ao A, Morrison BJ, Wang H, Lopez JA, Reynolds BA, Lu J. Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments. PLoS One 2011; 6: e18810.
38. Tinnanooru P, Dang VH, Nguyen TH, Lee GS, Choi KC, Jeung EB. Estrogen regulates the localization and expression of calbindin-D9k in the pituitary gland of immature male rats via the ERalpha-pathway. Mol Cell Endocrinol 2008; 285: 26-33.
39. Kaufmann SH, Ewing CM, Shaper JH. The erasable Western blot. Anal Biochem 1987; 161: 89-95.
40. Ozen S, Darcan S. Effects of environmental endocrine disruptors on pubertal development. J Clin Res Pediatr Endocrinol 2011; 3: 1-6.
41. Kortenkamp A. Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect 2007; 115(Suppl 1): 98-105.
42. Charles GD, Gennings C, Zacharewski TR, Gollapudi BB, Carney EW. An approach for assessing estrogen receptor-mediated interactions in mixtures of three chemicals: a pilot study. Toxicol Sci 2002; 68: 349-360.
43. Bouskine A, Nebout M, Brucker-Davis F, Benahmed M, Fenichel P. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ Health Perspect 2009; 117: 1053-1058.
44. Wozniak AL, Bulayeva NN, Watson CS. Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Perspect 2005; 113: 431-439.
45. Jeng YJ, Watson CS. Combinations of physiologic estrogens with xenoestrogens alter ERK phosphorylation profiles in rat pituitary cells. Environ Health Perspect 2011; 119: 104-112.
46. Alonso-Magdalena P, Ropero AB, Carrera MP, et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 2008; 3: e2069.
47. Zsarnovszky A, Le HH, Wang HS, Belcher SM. Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 2005; 146: 5388-5396.
48. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 2001; 109: 675-680.
49. Suzuki T, Ide K, Ishida M. Response of MCF-7 human breast cancer cells to some binary mixtures of oestrogenic compounds in-vitro. J Pharm Pharmacol 2001; 53: 1549-1554.
50. Han D, Tachibana H, Yamada K. Inhibition of environmental estrogen-induced proliferation of human breast carcinoma MCF-7 cells by flavonoids. In Vitro Cell Dev Biol Anim 2001; 37: 275-282.
51. Harvey PW. Parabens, oestrogenicity, underarm cosmetics and breast cancer: a perspective on a hypothesis. J Appl Toxicol 2003; 23: 285-288.
52. Darbre PD, Byford JR, Shaw LE, Horton RA, Pope GS, Sauer MJ. Oestrogenic activity of isobutylparaben in vitro and in vivo. J Appl Toxicol 2002; 22: 219-226.
53. Yamasaki K, Noda S, Imatanaka N, Yakabe Y. Comparative study of the uterotrophic potency of 14 chemicals in a uterotrophic assay and their receptor-binding affinity. Toxicol Lett 2004; 146: 111-120.
54. Shaw J, deCatanzaro D. Estrogenicity of parabens revisited: impact of parabens on early pregnancy and an uterotrophic assay in mice. Reprod Toxicol 2009; 28: 26-31.
55. Hossaini A, Larsen JJ, Larsen JC. Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays. Food Chem Toxicol 2000; 38: 319-323.
56. Okubo T, Yokoyama Y, Kano K, Kano I. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR. Food Chem Toxicol 2001; 39: 1225-1232.
57. Robert NJ, Martin L, Taylor CD, et al. Nuclear binding of the estrogen receptor: a potential predictor for hormone response in metastatic breast cancer. Breast Cancer Res Treat 1990; 16: 273-278.
58. Nguyen TH, Lee GS, Ji YK, Choi KC, Lee CK, Jeung EB. A calcium binding protein, calbindin-D9k, is mainly regulated by estrogen in the pituitary gland of rats during estrous cycle. Brain Res Mol Brain Res 2005; 141: 166-173.
59. Calabrese EJ. Hormesis is central to toxicology, pharmacology and risk assessment. Hum Exp Toxicol 2010; 29: 249-261.
60. Osborne CK, Schiff R, Arpino G, Lee AS, Hilsenbeck VG. Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy. Breast 2005; 14: 458-465.
61. Holm A, Baldetorp B, Olde B, Leeb-Lundberg LM, Nilsson BO. The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. J Vasc Res 2011; 48: 327-335.